Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.297 | 11 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.2722 | 11 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.27107 | 11 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.21738 | 11 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.21179 | 10 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.34712 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.39488 | 15 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.24841 | 11 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.2364 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.25953 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.26843 | 11 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.23962 | 11 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.26469 | 11 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.26644 | 11 |